PRIVILEGED & CONFIDENTIAL — ATTORNEY WORK PRODUCT
CALDERWOOD & HARKNESS LLP 7 Times Square New York, NY 10036 Tel: (212) 555-7800
Fax: (212) 555-7801
MEMORANDUM
To: James Prentice, Partner; Sandra Tung, Partner
From: Ryan Kowalski, Associate; Megan Chu, Associate
Date: April 16, 2025
Re: Summary of R&W Insurance Policy Terms and Negotiation Points — Ardent Capital Partners III LP Acquisition of Luminex Systems Holdings Inc.
Matter No.: 1001-00004
Policy No.: GSI-RWI-2025-04821 (Grandview Specialty Insurance Company)
Right-click to update Table of Contents
I. Executive Summary
The purpose of this memorandum is to summarize the material terms of the representations and warranties insurance ("R&W Insurance" or "RWI") policy currently being placed in connection with Ardent Capital Partners III LP's ("Ardent" or the "Buyer") proposed acquisition of Luminex Systems Holdings Inc. ("Luminex Holdings" or the "Target") for an aggregate equity consideration of $2,800,000,000, to be effected by means of a reverse triangular merger under the Delaware General Corporation Law. This memorandum further identifies and analyzes the principal negotiation points arising from the preliminary policy terms sheet provided by the carrier, and sets forth our recommendations for the negotiation of those terms to final binding form.
The RWI policy is being placed through Ashbury Risk Advisors LLC, an insurance brokerage specializing in transactional risk insurance, under the supervision of Philip Navarro, Managing Director, whose offices are located at 175 Water Street, 20th Floor, New York, NY 10038. Mr. Navarro has served as the primary broker contact for the placement and has coordinated all communications with prospective carriers throughout the marketing process.
The carrier selected for the placement is Grandview Specialty Insurance Company, a specialty insurance company domiciled in the State of Connecticut, with its principal offices at 100 Constitution Plaza, Hartford, CT 06103. The policy has been assigned Policy No. GSI-RWI-2025-04821 by Grandview's underwriting division.
The key commercial terms of the policy are as follows:
• Policy Type: Buyer-side representations and warranties insurance policy.
• Policy Limit: $420,000,000, equal to fifteen percent (15%) of the $2,800,000,000 enterprise value, which amount also corresponds to the indemnification cap established under the Agreement and Plan of Merger (the "Merger Agreement").
• Retention (Deductible): $14,000,000, equal to one-half of one percent (0.5%) of the $2,800,000,000 enterprise value, to be split equally between the selling stockholders and the Buyer ($7,000,000 each).
• Estimated Premium: $8,400,000, calculated at a rate of 2.0% on the $420,000,000 policy limit.
The RWI policy is designed to mirror, and function as an integrated component of, the indemnification structure established under the Merger Agreement dated March 24, 2025, among Ardent Apex Holdings Inc. (the acquisition vehicle), Ardent Apex Merger Sub Inc. (the merger subsidiary), and Luminex Systems Holdings Inc. (the Target). The policy is intended to serve as the Buyer's primary source of recovery for losses arising from breaches of the Target's representations and warranties, thereby facilitating a limited-recourse indemnification structure and enabling the selling stockholders to receive a greater portion of their merger consideration at closing with reduced post-closing exposure.
As discussed in detail below, a number of significant negotiation points remain open, most notably with respect to the scope of transaction-specific exclusions proposed by Grandview's underwriting team — including exclusions relating to antitrust and competition matters, CFIUS review, and transfer pricing — as well as the treatment of defense costs, the retention drop-down mechanism, subrogation rights against management rollover participants, and the no-claims declaration signatory requirements. This memorandum provides a detailed analysis of each of these points, together with our prioritized recommendations for the negotiation.
II. Transaction Overview (for Context)
To provide context for the policy terms and negotiation points discussed in this memorandum, set forth below is a summary of the principal terms of the acquisition transaction in connection with which the RWI policy is being placed.
A. Transaction Structure
The transaction is structured as a reverse triangular merger under the Delaware General Corporation Law. Under the terms of the Merger Agreement, Ardent Apex Merger Sub Inc. ("Merger Sub"), a newly formed Delaware corporation and wholly owned subsidiary of Ardent Apex Holdings Inc. ("Apex Holdings"), will merge with and into Luminex Systems Holdings Inc., with Luminex Holdings surviving the merger as a wholly owned subsidiary of Apex Holdings. Apex Holdings is itself a newly formed acquisition vehicle organized by Ardent Capital Partners III LP for the purpose of consummating this transaction.
B. Parties
Buyer: Ardent Capital Partners III LP, a Delaware limited partnership, with its principal offices at 399 Park Avenue, 42nd Floor, New York, NY 10022. Ardent Capital Partners III LP is a private equity fund with total committed capital of $12.5 billion (Fund III, vintage 2023). The fund is managed by its Co-Managing Partners, Theodore "Ted" Hargrove and Victoria Langford. Ardent Capital Partners III LP is the indirect equity holder of Apex Holdings and the ultimate economic acquirer of the Target.
Target: Luminex Systems Holdings Inc., a Delaware corporation (EIN: 86-2547193), with its principal offices at 2100 Reston Gateway Drive, Suite 800, Reston, VA 20191. Luminex Holdings is an intermediate U.S. holding company within the Luminex corporate group and serves as the direct and indirect parent of Luminex's operating subsidiaries. Luminex Holdings was incorporated in Delaware on June 14, 2021, as part of a U.S. parent restructuring within the broader Luminex corporate family.
Ultimate Parent: Luminex Systems AG, a Swiss Aktiengesellschaft organized under the laws of Switzerland, with its registered offices at Bahnhofstrasse 71, 8001 Zürich, Switzerland. Luminex Systems AG is led by Chief Executive Officer Dr. Stefan Kessler and Chief Financial Officer Annelise Gruber.
C. Deal Value and Consideration
The aggregate equity value of the transaction is $2,800,000,000, payable in cash at a price of $20.00 per share on the 140,000,000 fully diluted shares of Luminex Holdings outstanding as of the signing date. This valuation reflects the following financial metrics based on Luminex's 2024 fiscal year performance:
• 2024 Revenue: $487,000,000 (of which $441,000,000 constitutes annual recurring revenue ("ARR") and $46,000,000 constitutes professional services revenue).
• 2024 Adjusted EBITDA: $121,800,000 (representing a 25.0% Adjusted EBITDA margin).
• EV/Revenue Multiple: 5.75x.
• EV/EBITDA Multiple: 22.99x.
D. Selling Stockholders
The selling stockholders of Luminex Holdings and their respective ownership interests and merger consideration are as follows:
The management rollover of $405,020,000 represents approximately 51.7% of the total management/employee consideration. The principal rollover participants are Dr. Stefan Kessler (CEO, $142,800,000 rollover), Annelise Gruber (CFO, $58,800,000 rollover), Dr. Markus Vogt (CTO, $58,520,000 rollover), and other management and employee participants ($144,900,000 in aggregate rollover).
E. Key Dates and Advisors
• Merger Agreement Execution Date: March 24, 2025.
• Anticipated Closing Date: July–August 2025 (subject to satisfaction of closing conditions, including regulatory approvals).
• Seller's Counsel: Caldwell, Raines & Sheppard LLP (Patricia Okonkwo, Partner).
• Buyer's Counsel: Calderwood & Harkness LLP (James Prentice, Partner; Sandra Tung, Partner).
• Buyer's Financial Advisor: Whitfield Partners LLC (Christopher Brennan, Managing Director).
• Seller's Financial Advisor: Pinehurst Rothwell & Co. (Samantha Delacroix, Managing Director).
III. Named Insured and Additional Insureds
A. Named Insured
The Named Insured under the policy is Ardent Apex Holdings Inc., a Delaware corporation (EIN: 93-2178435), which serves as the acquisition vehicle for the transaction and will be the direct parent of Luminex Holdings following the closing of the merger.
B. Additional Insureds
The policy provides for the following entities to be designated as Additional Insureds under the policy:
(a) Ardent Capital Partners III LP (the Fund);
(b) Ardent Capital GP III LLC (the general partner of the Fund);
(c) Ardent Apex Merger Sub Inc. (the merger subsidiary, pre-closing);
(d) Luminex Systems Holdings Inc. (in its capacity as the surviving corporation of the merger, post-closing); and
(e) The respective successors and assigns of each of the foregoing.
The inclusion of each of these entities as Additional Insureds is appropriate to ensure that coverage under the policy runs to the benefit of the entire Ardent ownership chain and extends to the surviving entity post-merger. This is a standard structuring approach for buyer-side RWI policies in leveraged buyout transactions.
C. Co-Investor Additional Insureds
In addition to the foregoing, two co-investors participating in the equity financing of the acquisition are expected to be added as Additional Insureds under the policy:
• Northvale Sovereign Holdings Ltd., which is committing $200,000,000 in co-investment equity to the transaction (contact: Ahmad Al-Rashid, Managing Director).
• Summit Ridge Capital Partners LP, which is committing $100,000,000 in co-investment equity to the transaction (contact: Karen Lindstrom, Partner).
A negotiation point remains open regarding the scope of coverage for co-investors. Grandview's preliminary terms sheet contemplates that co-investors will be added as Additional Insureds but subject to certain limitations on their ability to make direct claims under the policy independent of the Named Insured. We recommend that Northvale and Summit Ridge receive full and unrestricted Additional Insured status, with the right to submit claims directly to the carrier, consistent with their economic stake in the transaction. This is addressed further in Section XI.B.13 below.
D. Management Rollover Participants
A further question has been raised as to whether the management rollover participants — specifically Dr. Stefan Kessler, Annelise Gruber, and Dr. Markus Vogt — should be named as Additional Insureds under the policy. These individuals occupy a dual role in the transaction: they are selling stockholders who are receiving merger consideration (and thus are in part on the "sell side" of the transaction), but they are also rolling over a substantial portion of their equity ($405,020,000 in aggregate) and will serve as post-closing equity holders and members of management of Apex Holdings.
We do not recommend naming the rollover management participants as Additional Insureds at this time, as doing so could create conflicts with respect to claims arising from their conduct or knowledge in their capacity as former officers and directors of the Target. However, the subrogation provisions of the policy must be carefully structured to protect these individuals from carrier recovery actions in their capacity as post-closing equity holders, as discussed in Section VIII.D below.
IV. Policy Limit and Structure
A. Aggregate Policy Limit
The policy provides an aggregate limit of liability of $420,000,000. This limit represents fifteen percent (15%) of the $2,800,000,000 enterprise value and is designed to mirror the indemnification cap set forth in the Merger Agreement. Under the Merger Agreement, the aggregate liability of the selling stockholders for breaches of representations and warranties (exclusive of fraud claims) is capped at $420,000,000, and the RWI policy limit has been set at the same level to provide dollar-for-dollar coverage up to the cap.
The $420,000,000 limit is a single aggregate limit applicable to all claims under the policy. There is no per-claim sublimit or per-representation sublimit unless otherwise negotiated. Once the aggregate of all covered losses under the policy equals or exceeds $420,000,000 (inclusive of amounts paid and amounts reserved for pending claims), the policy will be fully exhausted. We note that, in the current market, a 15% policy limit relative to enterprise value is within the typical range for transactions of this size and complexity, where limits generally range from 10% to 20% of enterprise value.
B. Policy Period
The policy is a claims-made policy, meaning that coverage is available only for claims that are both first made and reported to the carrier during the applicable policy period. The policy period is structured to align with the survival periods established in the Merger Agreement for the various categories of representations and warranties:
(i) Inception Date: The policy becomes effective as of the closing date of the merger (currently targeted for July–August 2025). No coverage is available for pre-closing events or claims, and the policy does not attach until all conditions to closing have been satisfied or waived and the merger has been consummated.
(ii) General Representations and Warranties: The policy provides an 18-month policy period from the closing date with respect to breaches of general representations and warranties. This period is coterminous with the survival period applicable to general representations under the Merger Agreement.
(iii) Fundamental Representations: The policy provides a 36-month policy period from the closing date with respect to breaches of the fundamental representations identified in the Merger Agreement (as enumerated in Section VI.C below). This extended period is likewise coterminous with the enhanced survival period applicable to fundamental representations under the Merger Agreement.
(iv) Tax Representations: With respect to breaches of the Target's tax representations, the policy provides coverage for a period extending until 60 days after the expiration of the applicable statute of limitations for the assessment of the relevant tax liability. This matches the survival period for tax representations under the Merger Agreement and is designed to ensure that coverage remains available for the full period during which a tax authority may assert a claim or assessment.
All claims must be first made against the insured and reported to Grandview in writing during the applicable policy period. We address the negotiation of a claims-reporting grace period in Section XI.B.10 below.
C. Retention (Deductible)
1. Retention Amount
The policy includes a total retention of $14,000,000, equal to one-half of one percent (0.5%) of the $2,800,000,000 enterprise value. The retention functions as a deductible: the insured must bear aggregate losses equal to the retention amount before the policy responds. Once aggregate covered losses exceed $14,000,000, the carrier will pay covered losses in excess of the retention up to the $420,000,000 aggregate policy limit.
The retention amount of 0.5% of enterprise value is at the lower end of the current market range for transactions of this size, where retentions typically range from 0.50% to 1.00% of enterprise value. The favorable retention level reflects the relatively clean diligence profile of the Target and the competitive placement process conducted by Ashbury Risk Advisors.
2. Retention Split
The retention is to be split equally (50/50) between the selling stockholders and the Buyer:
• Seller's share: $7,000,000, to be borne by the selling stockholders of Luminex Holdings (allocated pro rata among the selling stockholders in accordance with the Merger Agreement).
• Buyer's share: $7,000,000, to be borne by Ardent Apex Holdings Inc.
The seller's portion of the retention is backstopped by the $140,000,000 escrow held by Continental Fiduciary Trust Company (Escrow Account Reference: CFT-ESC-2025-7894). The escrow period is 18 months following the closing date, coterminous with the survival period for general representations and warranties. The escrow provides ample credit support for the seller's $7,000,000 share of the retention as well as for any other direct seller indemnification obligations that may arise below the RWI policy attachment point.
3. Retention Application
The retention applies on a first-dollar basis. Losses are counted against the retention as they are incurred, and once the aggregate of all covered losses equals or exceeds $14,000,000, the policy responds for all additional covered losses up to the $420,000,000 limit. Losses borne by the sellers under the Merger Agreement's direct indemnification provisions count toward the satisfaction of the retention, such that amounts recovered by the Buyer from the sellers (including from the escrow) reduce the retention on a dollar-for-dollar basis.
4. Drop-Down Retention (Negotiation Point)
A significant negotiation point relates to whether the retention should drop down after a specified period. It is common in the current market for buyer-side RWI policies to provide that the retention decreases — typically to 50% of the stated retention or to zero — after the first 12 months of the policy period with respect to non-fundamental representations. The rationale for this drop-down is that the risk of latent breaches diminishes as the Buyer completes its post-closing integration and gains deeper visibility into the Target's operations and liabilities.
We recommend negotiating a 50% drop-down of the retention from $14,000,000 to $7,000,000 after the first 12 months of the policy period with respect to claims arising from breaches of non-fundamental representations. This would have the effect of reducing the Buyer's aggregate first-dollar exposure from $14,000,000 to $7,000,000 during the final 6 months of the general representation policy period. This negotiation point is addressed further in Section XI.A.4 below.
V. Premium and Costs
The estimated total cost of the RWI policy placement is summarized as follows:
A. Premium
The estimated premium for the policy is $8,400,000, calculated as a rate of 2.0% applied to the $420,000,000 policy limit. This rate is consistent with the current market range for buyer-side RWI policies on transactions of this size and complexity, where rates generally range from 1.75% to 3.00% depending on deal-specific risk factors, the scope of exclusions, and competitive market conditions. Ashbury Risk Advisors obtained indications from three carriers during the marketing process, and the Grandview rate of 2.0% represented the most competitive premium for the coverage terms offered.
B. Premium Allocation
The premium is to be paid by the Buyer (Ardent Apex Holdings Inc.). The premium has been included in the Buyer's estimated transaction expenses of $62,000,000, which also include legal fees, advisory fees, financing costs, and other closing-related expenses. The allocation of the premium to the Buyer is standard for buyer-side RWI policies and is consistent with the structure under the Merger Agreement, which contemplates that each party bears its own transaction expenses.
C. Underwriting Fee
Grandview has indicated that an underwriting fee / diligence access fee will be payable at the inception of underwriting. The amount of this fee is to be confirmed but is expected to fall within the range of $50,000 to $75,000, which is customary for transactions of this size. The underwriting fee is non-refundable and is payable regardless of whether the policy is ultimately bound.
D. Broker Commission
The broker commission payable to Ashbury Risk Advisors LLC is included within the premium amount and will be paid directly by Grandview Specialty Insurance Company to Ashbury out of the premium proceeds. No separate broker fee is payable by the Buyer or the insured.
E. State Surplus Lines Taxes and Fees
Because Grandview Specialty Insurance Company operates as a surplus lines carrier, the placement is subject to state surplus lines taxes and filing fees. Based on Grandview's Connecticut domicile and the jurisdictions in which the insured entities are located, the estimated surplus lines taxes and fees are approximately $250,000 to $400,000. The final amount will depend on the allocation of premium among applicable jurisdictions and will be confirmed by Ashbury Risk Advisors upon binding.
F. Total Estimated Insurance Cost
The total estimated cost of the RWI policy placement, inclusive of premium, surplus lines taxes, and filing fees, is approximately $8,650,000 to $8,800,000. This does not include the underwriting fee referenced above.
VI. Covered Representations and Warranties
A. Scope of Coverage
The policy covers all representations and warranties made by Luminex Systems Holdings Inc. (the "Target" or the "Company") as set forth in the Merger Agreement dated March 24, 2025. This is a buyer-side RWI policy, meaning that it provides coverage to the Buyer (and the other insureds) for losses arising from breaches of the Target's representations and warranties. The policy does not cover breaches of the Buyer's own representations and warranties under the Merger Agreement, nor does it cover breaches of any representations or warranties made by any party in any ancillary agreement (unless specifically endorsed).
The coverage is intended to be coextensive with the scope of the Target's representations and warranties as set forth in the Merger Agreement, subject to the exclusions discussed in Section VII below and the policy's general terms and conditions. Coverage attaches upon the occurrence of a breach of any covered representation or warranty that results in a covered loss to an insured, provided that the applicable retention has been satisfied and the claim is timely made and reported during the applicable policy period.
B. Key Covered Representations (Non-Exhaustive List)
The following is a non-exhaustive summary of the principal categories of representations and warranties made by the Target in the Merger Agreement that are covered under the policy:
1. Organization and Good Standing. Representations regarding the due organization, valid existence, and good standing of the Target and each of its subsidiaries — including Luminex Systems AG (Switzerland), Luminex US Inc. (United States), Luminex UK Ltd. (United Kingdom), Veltronix GmbH (Germany), and Luminex Systems Pte. Ltd. (Singapore) — in their respective jurisdictions of incorporation or organization, and their qualification to do business in each jurisdiction where the nature of their business or ownership of property requires such qualification.
2. Authorization and Enforceability. Representations that the Target has the corporate power and authority to execute and deliver the Merger Agreement and to consummate the transactions contemplated thereby, and that the Merger Agreement constitutes a valid and binding obligation of the Target, enforceable in accordance with its terms.
3. Capitalization. Representations regarding the authorized and outstanding capital stock of the Target, including confirmation that there are 140,000,000 fully diluted shares outstanding, the absence of undisclosed equity interests, options, warrants, or convertible securities, and the accuracy of the capitalization table provided in the Disclosure Schedules.
4. Financial Statements. Representations that the Target's audited consolidated financial statements (audited by Hargrove Thornton LLP, with Margaret Dawson serving as lead audit partner) have been prepared in accordance with GAAP, consistently applied, and present fairly in all material respects the financial condition and results of operations of the Target and its subsidiaries as of the dates and for the periods covered.
5. Absence of Undisclosed Liabilities. Representations that the Target and its subsidiaries have no liabilities or obligations of any nature (whether accrued, absolute, contingent, or otherwise) other than those reflected or reserved against in the most recent audited balance sheet, incurred in the ordinary course of business since the balance sheet date, or otherwise disclosed in the Disclosure Schedules.
6. Absence of Certain Changes. Representations that, since the most recent balance sheet date, the Target has conducted its business in the ordinary course and there has been no event, change, effect, or development that, individually or in the aggregate, has had or would reasonably be expected to have a Material Adverse Effect on the Target.
7. Tax Matters. Representations regarding the timely filing of all tax returns, the payment of all taxes due, the absence of material tax disputes or assessments, compliance with transfer pricing rules and regulations, and the adequacy of tax reserves.
8. Compliance with Laws. Representations that the Target and its subsidiaries are in compliance in all material respects with all applicable laws, rules, and regulations, including data privacy and data protection laws and regulations (specifically including the EU General Data Protection Regulation ("GDPR"), the Swiss Federal Act on Data Protection ("FADP"), the California Consumer Privacy Act ("CCPA"), and the Singapore Personal Data Protection Act ("PDPA")).
9. intellectual Property. Representations regarding the Target's ownership of and rights in its intellectual property, including the "Luminex One" cloud-based procurement-automation platform, all patents, trademarks, service marks, copyrights, trade secrets, and domain names, open-source software compliance, and intercompany intellectual property licensing arrangements (including the current royalty rate of 4.5% of U.S. net revenues under the intercompany IP license agreement between Luminex Systems AG and Luminex US Inc.).
10. Material Contracts. Representations regarding the Target's material contracts, including approximately 340 commercial contracts with customers and vendors, and 26 enterprise license agreements that contain change-of-control provisions that may be triggered by the consummation of the merger. Representations include that all material contracts are valid, binding, and in full force and effect, and that neither the Target nor any counterparty is in material breach or default thereunder.
11. Employee Benefits and Labor Matters. Representations regarding the Target's employee benefit plans, compensation arrangements, compliance with ERISA and the Internal Revenue Code (with respect to U.S. plans), and labor and employment matters across the Target's approximately 4,200 global employees, of whom approximately 1,650 are located in the United States.
12. Environmental Matters. Representations regarding compliance with environmental laws and regulations, the absence of environmental liabilities, and the condition of owned or leased real property.
13. Real Property and Leases. Representations regarding the Target's owned and leased real property, including the status and enforceability of all real property leases.
14. Litigation and Proceedings. Representations regarding the absence of pending or threatened litigation, arbitration, governmental investigation, or other legal proceedings against the Target or its subsidiaries that would, individually or in the aggregate, reasonably be expected to result in liability in excess of the disclosed thresholds.
15. Government Contracts. Representations regarding the Target's government contracts with the U.S. Department of Defense ("DOD"), the U.S. Department of Energy ("DOE"), and the General Services Administration ("GSA"), including compliance with applicable procurement regulations, the International Traffic in Arms Regulations ("ITAR"), the Federal Acquisition Regulation ("FAR"), the Defense Federal Acquisition Regulation Supplement ("DFARS"), and cybersecurity requirements.
16. Insurance. Representations regarding the Target's existing insurance coverage, including the maintenance of all required insurance policies in full force and effect.
17. Brokers and Finders. Representations that no broker, finder, or investment banker (other than the disclosed financial advisors) is entitled to any fee or commission in connection with the merger.
C. Fundamental Representations (Enhanced Coverage / Extended Survival)
The following representations and warranties are designated as "Fundamental Representations" under both the Merger Agreement and the RWI policy. Fundamental Representations are subject to enhanced treatment, including a longer survival period (36 months post-closing, as compared to 18 months for general representations) and exclusion from certain limitations on indemnification that apply to general representations:
(a) Organization and existence;
(b) Authority and due authorization;
(c) Capitalization;
(d) Title to equity interests in subsidiaries;
(e) Tax matters; and
(f) Brokers' fees.
The designation of the foregoing representations as Fundamental Representations is consistent with market practice and reflects their heightened importance to the Buyer's investment thesis and valuation analysis. The 36-month policy period for Fundamental Representations is coterminous with the survival period established in the Merger Agreement.
VII. Exclusions
The policy contains a number of exclusions from coverage, which fall into three categories: (A) standard market exclusions, (B) transaction-specific exclusions identified during Grandview's underwriting process, and (C) a seller knowledge exclusion. Each category is discussed in detail below.
A. Standard / Market Exclusions
The following exclusions are standard in the current R&W insurance market and are generally accepted by buyers and their counsel as non-negotiable terms:
1. Fraud or Willful Misconduct. The policy excludes coverage for losses arising from or attributable to fraud or willful misconduct by any insured party. This is a universal exclusion and is not subject to negotiation. We note that the policy provides the carrier with subrogation rights against all parties (including sellers) in cases of fraud, as discussed in Section VIII.D below.
2. Purchase Price Adjustments. The policy excludes coverage for any adjustment to the merger consideration pursuant to the working capital true-up mechanism established under the Merger Agreement. The Merger Agreement establishes a target net working capital of $48,500,000, with a collar of plus or minus $2,500,000, and provides for a post-closing adjustment to the merger consideration based on the difference between the estimated closing net working capital and the final determined net working capital. Any adjustment within or outside the collar is excluded from RWI coverage, as such adjustments are inherent to the transaction mechanics and do not constitute "losses" within the meaning of the policy.
3. Forward-Looking Statements, Projections, and Estimates. The policy excludes coverage for losses arising from or attributable to any forward-looking statement, projection, forecast, or estimate, including financial projections and pro forma financial information provided by the Target's management or by Pinehurst Rothwell & Co. in the confidential information memorandum or management presentations furnished to prospective buyers during the sale process. This exclusion is standard and reflects the principle that RWI policies cover only breaches of backward-looking factual representations, not the failure of prospective projections to materialize.
4. Consequential, Punitive, and Multiplied Damages. The policy excludes coverage for consequential, special, punitive, exemplary, or multiplied damages, except to the extent that such damages are awarded to a third party in a third-party claim and are otherwise covered under the policy. This carve-out for third-party awards is consistent with market practice and ensures that the insured is not left unprotected in circumstances where a court or tribunal awards enhanced damages against the insured in litigation initiated by a third party.
5. Pension and Benefit Plan Underfunding. The policy excludes coverage for losses arising from or attributable to any unfunded or underfunded liability of a defined benefit pension plan or other post-employment benefit plan maintained by the Target or any of its subsidiaries, to the extent such underfunding constitutes the difference between plan assets and plan obligations under applicable accounting standards.
6. Adequacy of Reserves. The policy excludes coverage for losses arising from or attributable to the inadequacy of any reserves established by the Target on its financial statements, including reserves for warranty claims, litigation, returns, bad debts, or other contingencies.
7. Covenant Breaches. The policy excludes coverage for losses arising from breaches of covenants, agreements, or undertakings set forth in the Merger Agreement, as distinguished from breaches of representations and warranties. RWI policies, by their nature, cover only representation and warranty breaches, and this exclusion clarifies that operating covenants (including both pre-closing interim covenants and post-closing covenants) are outside the scope of coverage.
8. Transfer Pricing Adjustments. The policy excludes coverage for losses arising from any adjustment to transfer prices or intercompany pricing arrangements by any tax authority. This exclusion is discussed further below as a negotiation point, given the proposed restructuring of the intercompany royalty rate from 4.5% to 6.0% and the potential for transfer pricing exposure in connection with Luminex's cross-border operations.
B. Transaction-Specific Exclusions (Identified by Grandview Underwriting)
In addition to the standard market exclusions described above, Grandview's underwriting team has identified the following transaction-specific exclusions, each of which is based on risk factors specific to the Luminex acquisition. Several of these exclusions are the subject of ongoing negotiation, as discussed in Section XI below.
1. Antitrust / Competition Matters. Grandview has proposed an exclusion for all losses arising from or relating to any antitrust or competition matter associated with the competitive overlap between the Target and Vectis Solutions LLC, an existing portfolio company of Ardent Capital Partners Fund II. The Target holds an approximately 18% market share in the procurement-automation SaaS sector, while Vectis Solutions holds an approximately 7% market share, resulting in a combined post-acquisition market share of approximately 25%. The Hart-Scott-Rodino pre-merger notification filing has been submitted (HSR Transaction No. HSR-20250328-4192), and the Federal Trade Commission ("FTC") has initiated a review of the competitive implications of the transaction. Grandview's proposed exclusion extends broadly to all antitrust-related losses, including losses arising from any required remedies, divestitures, or conduct restrictions imposed by the FTC or any other competition authority.
As discussed in Section XI.A.1 below, we recommend narrowing this exclusion to cover only losses directly arising from the FTC's review of the Luminex/Vectis overlap and any required divestiture of Vectis Solutions LLC, and to preserve coverage for the Target's general antitrust compliance representations.
2. CFIUS-Related Exclusion. Grandview has proposed an exclusion for all losses arising from or relating to the review of the transaction by the Committee on Foreign Investment in the United States ("CFIUS"). This exclusion relates to the fact that Luminex US Inc. maintains active contracts with the U.S. Department of Defense, the U.S. Department of Energy, and the General Services Administration, and the acquisition by a fund with co-investment from Northvale Sovereign Holdings Ltd. (a non-U.S. investor) may trigger CFIUS jurisdiction. A CFIUS filing has been submitted under Tracking No. CFIUS-2025-0087, and the review process is ongoing.
As discussed in Section XI.A.2 below, we recommend narrowing this exclusion to losses arising solely from any national-security mitigation agreement or similar conditions imposed by CFIUS, and to preserve coverage for the Target's general government-contract compliance representations.
3. Known Matters / Disclosure Schedule Matters. The policy contains an exclusion for any matter that is specifically disclosed in the Disclosure Schedules to the Merger Agreement. This exclusion applies to both the Buyer's and the Seller's Disclosure Schedules and is intended to exclude matters of which the Buyer had actual knowledge at signing. While this is a standard exclusion, the scope of "disclosed" is a significant negotiation point, as discussed in Section XI.B.9 below.
4. Certain Environmental Matters. Grandview has indicated that it may propose an exclusion for pre-existing environmental conditions at any owned or leased real property of the Target or its subsidiaries. The scope of this potential exclusion is subject to confirmation based on the results of the environmental due diligence review currently being finalized. We expect this exclusion, if proposed, to be limited to known pre-existing conditions identified in the environmental site assessments and to preserve coverage for the Target's general environmental compliance representations.
5. Sanctions / Export Control Matters. Grandview has indicated that it may propose an exclusion relating to compliance with Swiss, European Union, and United States sanctions regimes and export control laws, given Luminex's operations in the DACH region (Switzerland, Germany), APAC (Singapore), the United Kingdom, and the United States. The scope of this potential exclusion is under discussion. We recommend that if such an exclusion is included, it be limited to actual violations of applicable sanctions or export control laws and not extend to mere allegations of non-compliance, and that coverage remain available for representations regarding the Target's sanctions and export control compliance programs, as discussed in Section XI.B.12 below.
6. Interim Covenant Breaches. The policy excludes losses arising from any breach of the interim operating covenants set forth in the Merger Agreement for the period between signing and closing. These covenants include, among other things, restrictions on capital expenditures in excess of $5,000,000, new hires with base salary in excess of $250,000, contract commitments in excess of $2,000,000, and intellectual property licensing outside the ordinary course of business. Because these are covenants (not representations and warranties), losses arising from their breach are outside the scope of RWI coverage as a matter of policy structure. This exclusion is not a matter for negotiation, but we note it here for completeness and to distinguish it from the representation-based coverage provided by the policy.
C. Exclusion for Seller Knowledge
The policy contains a "seller knowledge" exclusion, pursuant to which coverage is not available for any breach of a representation or warranty that was actually known to specified individuals associated with the Target prior to the execution of the Merger Agreement. This exclusion is designed to prevent moral hazard by ensuring that the policy does not cover breaches that were known to the sellers at the time of signing but were not disclosed to the Buyer.
The named knowledge holders expected to be identified in the policy are:
(i) Dr. Stefan Kessler, Chief Executive Officer of Luminex Systems AG;
(ii) Annelise Gruber, Chief Financial Officer of Luminex Systems AG;
(iii) Dr. Markus Vogt, Chief Technology Officer of Luminex Systems AG; and
(iv) Roland Merz, Chairman of the Board of Directors of Luminex Systems AG.
A key negotiation point relates to the definition of "knowledge" employed in this exclusion. Grandview's preliminary terms sheet defines "knowledge" to include both actual knowledge and constructive knowledge (i.e., matters that the named individuals "knew or should have known" in the exercise of reasonable inquiry). We strongly recommend limiting the knowledge standard to the actual knowledge of the named individuals, without imputing constructive knowledge. A constructive knowledge standard would effectively impose a duty of inquiry on the knowledge holders and could result in the carrier denying coverage based on the assertion that a knowledge holder "should have known" of a particular matter, even if that individual had no actual awareness of the relevant facts. The limitation to actual knowledge is supported by prevailing market practice and is consistent with the knowledge qualifier used in the Merger Agreement's representations and warranties. This negotiation point is addressed further in Section XI.B.8 below.
VIII. Key Policy Terms and Conditions
A. Definition of Loss
The policy defines "Loss" to include all damages, losses, liabilities, costs, and expenses (including reasonable attorneys' fees and expenses of investigation and defense) incurred by the insured as a result of a breach of a covered representation or warranty. This definition is broadly consistent with the definition of "Losses" in the Merger Agreement's indemnification provisions and provides comprehensive coverage for the full range of economic harm that may result from a representation and warranty breach.
Several aspects of the Loss definition warrant particular attention:
Defense Costs. A critical negotiation point is whether defense costs (including attorneys' fees, expert fees, and other costs of defending or investigating a claim) erode the $420,000,000 aggregate policy limit or are covered as supplementary amounts outside the limit. Under the preliminary terms sheet, defense costs are treated as part of the aggregate limit, meaning that every dollar spent on defense reduces the amount of coverage available for substantive losses. We strongly recommend negotiating for defense costs to be covered outside the aggregate limit, as discussed in Section XI.A.5 below. Given the complexity and cross-border nature of the Target's operations, any significant claim under the policy could involve substantial defense costs, and treating those costs as eroding the limit would materially diminish the effective coverage available to the Buyer.
Diminution-in-Value Claims. We also recommend confirming that the Loss definition encompasses diminution-in-value claims — i.e., claims based on the theory that a breach of a representation or warranty has reduced the value of the acquired business below the purchase price paid. Diminution-in-value damages are an important category of loss in the RWI context, particularly where a breach does not give rise to a readily quantifiable out-of-pocket loss but instead affects the economic value of the acquired enterprise.
Tax Gross-Up. The Loss definition should provide that losses are calculated (a) net of any tax benefit actually realized by the insured as a result of the underlying loss, and (b) grossed up for any taxes imposed on insurance proceeds received by the insured, such that the insured is made whole on an after-tax basis. This treatment is consistent with the Merger Agreement's indemnification provisions and with standard RWI policy drafting.
B. Materiality Scrape
The policy incorporates a double materiality scrape, which is one of the most commercially significant features of the RWI policy:
(i) Breach Determination Scrape. For purposes of determining whether a breach of a representation or warranty has occurred, all materiality qualifiers, Material Adverse Effect qualifiers, and similar qualifications contained in the representations and warranties are disregarded. This means that a representation that is qualified by materiality will be read as if the materiality qualifier were not present, and any inaccuracy — regardless of whether it rises to the level of "materiality" — will constitute a breach.
(ii) Loss Calculation Scrape. For purposes of calculating the amount of loss resulting from a breach, all materiality qualifiers, Material Adverse Effect qualifiers, and similar qualifications are likewise disregarded. This ensures that the full amount of loss is recoverable, not merely the incremental loss above a materiality threshold.
The double materiality scrape is a standard feature of buyer-side RWI policies and matches the corresponding materiality scrape provisions in the Merger Agreement's indemnification article. We note the importance of confirming that the Merger Agreement's definition of "Material Adverse Effect" — which includes customary carve-outs for (a) general economic or market conditions, (b) industry-wide conditions affecting the procurement-automation SaaS sector, (c) changes in applicable law, (d) effects of COVID-19 or any epidemic, pandemic, or similar public health event, and (e) changes in GAAP or other applicable accounting standards, in each case except to the extent that such conditions or events disproportionately affect the Target relative to other similarly situated companies in its industry — is properly reflected in the policy and that the policy's materiality scrape operates consistently with the Merger Agreement.
C. No-Claims Declaration (NCD)
The Buyer and its representatives will be required to deliver a No-Claims Declaration ("NCD") to the carrier at or prior to the closing of the merger. The NCD is a written certification in which the signatories confirm that, as of the date of closing, no insured has knowledge of any fact, circumstance, or condition that would reasonably be expected to give rise to a claim under the policy.
The NCD serves as a condition precedent to the effectiveness of the policy and is designed to protect the carrier against the risk that the insured may seek to recover for a loss that was already known at the time of closing. The NCD is a standard requirement in the RWI market.
A negotiation point has arisen regarding the identity and number of signatories to the NCD. Grandview has requested that the NCD be signed by all members of the Ardent Capital Investment Committee and all members of the Calderwood & Harkness deal team with knowledge of the transaction. We regard this request as overbroad and inconsistent with market practice. We recommend limiting the NCD signatories to no more than two individuals: specifically, Ted Hargrove (or, in the alternative, Victoria Langford) as the responsible Ardent Capital managing partner, and James Prentice as the responsible Calderwood & Harkness partner. This limitation is appropriate because (a) the NCD should be signed only by individuals with overall supervisory responsibility for the transaction, not by every team member with peripheral involvement, and (b) expanding the signatory group increases the risk that a junior team member's awareness of a minor diligence finding could be imputed to the insured and used by the carrier to deny coverage. This negotiation point is addressed further in Section XI.A.7 below.
D. Subrogation Rights
The policy provides the carrier with the right of subrogation against the selling stockholders and other third parties for claims paid under the policy. However, the subrogation provisions are subject to certain important limitations and carve-outs:
(i) No Subrogation Against Selling Stockholders (Except for Fraud). The policy provides that the carrier will not exercise subrogation rights against the selling stockholders (Ridgeline Growth Equity Fund II LP, Meridian Venture Partners IV LP, and the management/employee sellers) except in cases of actual fraud by the selling stockholder against whom subrogation is sought. This is a critical provision from the sellers' perspective, as the commercial purpose of the RWI policy is to relieve the sellers from post-closing indemnification exposure. Without this limitation, the carrier could, after paying a claim, seek to recover from the sellers — effectively shifting the loss back to the sellers and nullifying the benefit of the RWI structure.
(ii) No Subrogation Against Management Rollover Participants. The policy should provide that the carrier will not exercise subrogation rights against the management rollover participants — specifically, Dr. Stefan Kessler ($142,800,000 rollover), Annelise Gruber ($58,800,000 rollover), Dr. Markus Vogt ($58,520,000 rollover), and other management and employee participants ($144,900,000 in aggregate rollover) — in their capacity as post-closing equity holders of Apex Holdings. This limitation is essential to the commercial structure of the transaction. If the carrier were permitted to subrogate against rollover management, the effect would be to require those individuals to indemnify the Buyer (through the intermediary of the carrier), which would undermine the entire purpose of the RWI placement and could disrupt the post-closing alignment of interests between the Buyer and continuing management.
(iii) Fraud Exception Preserved. Notwithstanding the foregoing limitations, the policy preserves the carrier's right of subrogation against any person in cases of actual fraud committed by such person. This is a standard exception and is not subject to negotiation.
We recommend that the no-subrogation protection for management rollover participants be drafted in explicit and unambiguous terms, with a specific enumeration of the protected individuals and their respective rollover amounts. This negotiation point is addressed further in Section XI.A.6 below.
E. Assignment and Change of Control
The policy is assignable to successors in interest of the Named Insured upon a subsequent sale, merger, or other change of control of Luminex Holdings or Apex Holdings, subject to prior written notice to Grandview Specialty Insurance Company. The assignability of the policy is important for Ardent's ultimate exit strategy, as the policy coverage will need to follow the acquired business in the event of a subsequent sale, IPO, or recapitalization during the typical private equity hold period of three to seven years.
We recommend confirming that the assignment provision requires only written notice to Grandview, and not Grandview's prior written consent. An assignment-by-consent-only provision could create an obstacle to Ardent's exit if Grandview were to withhold consent unreasonably or impose conditions on the assignment. This negotiation point is addressed in Section XI.B.11 below.
F. Governing Law and Dispute Resolution
The policy is governed by the laws of the State of New York, without giving effect to principles of conflicts of law. This governing law provision is consistent with the choice of law applicable to the Merger Agreement's indemnification provisions and ensures uniformity in the interpretation and enforcement of the policy and the Merger Agreement.
With respect to dispute resolution, we recommend that disputes arising under the policy be resolved by binding arbitration rather than litigation. Arbitration offers several advantages in the RWI context, including confidentiality (which is important given the sensitive commercial and financial information that would be disclosed in any coverage dispute), speed relative to court proceedings, and the ability to select arbitrators with expertise in insurance and transactional matters. The preliminary terms sheet indicates that Grandview is amenable to arbitration, but the specific arbitral rules, seat, and tribunal composition remain to be negotiated.
IX. Relationship to Merger Agreement Indemnification Provisions
The RWI policy is designed to function as an integrated component of the indemnification framework established under the Merger Agreement. Set forth below is a discussion of the key points of interaction between the policy and the Merger Agreement's indemnification provisions.
A. Indemnification Cap
The Merger Agreement establishes an aggregate indemnification cap of $420,000,000 (fifteen percent of the $2,800,000,000 enterprise value) for the sellers' liability for breaches of representations and warranties (exclusive of fraud claims, for which no cap applies). The RWI policy limit of $420,000,000 is set at the same level, providing dollar-for-dollar coverage up to the indemnification cap. Following the closing of the merger, the Buyer's primary recourse for representation and warranty breaches will be the RWI policy rather than direct claims against the selling stockholders, subject to the retention as described above.
This structure is designed to permit the selling stockholders — in particular, the financial sponsors Ridgeline Growth Equity Fund II LP and Meridian Venture Partners IV LP — to achieve a substantially clean exit at closing, with limited post-closing indemnification exposure beyond their pro rata share of the $7,000,000 seller retention (which is in any event backstopped by the escrow). The structure also benefits the Buyer by providing access to a well-capitalized insurance carrier as the counterparty for indemnification claims, rather than relying on the creditworthiness and willingness-to-pay of the selling stockholders.
B. Escrow